Notice names this product. American Regent’s Papaverine HCl Injection is named in FDA Class I recall D-0800-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde Identifying details: Lot #: 25202, Exp. Date: 11/30/2026.. Units affected: 86,100 vials. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
Company / brand: American Regent recalls
Affected product: Papaverine HCl Injection recall status
Official ID D-0800-2026 · Official record ↗
See all American Regent recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.